|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
KR101011373B1
(ko)
*
|
2002-07-11 |
2011-01-28 |
비큐론 파마슈티컬스 인코포레이티드 |
항균작용을 갖는 ｎ-히드록시아미드 유도체
|
|
CA2851462A1
(en)
*
|
2003-01-08 |
2004-07-29 |
University Of Washington |
Antibacterial agents
|
|
PL2256106T3
(pl)
|
2003-07-22 |
2015-08-31 |
Astex Therapeutics Ltd |
Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
|
|
BRPI0415179A
(pt)
|
2003-10-07 |
2006-11-28 |
Renovis Inc |
derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
|
|
US7687435B2
(en)
*
|
2003-12-19 |
2010-03-30 |
Basf Aktiengesellschaft |
Benzoyl-substituted phenylalanineamides
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
US7638513B2
(en)
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
WO2006022442A1
(ja)
*
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
US7776869B2
(en)
*
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
ES2380904T3
(es)
|
2005-01-26 |
2012-05-21 |
Allergan, Inc. |
Composiciones farmacéuticas que tienen un efecto analgésico y contienen 1-bencil-1-hidroxi-2,3-diamino-propil aminas, amidas del ácido 3-bencil-3-hidroxi-2-amino propiónico o compuestos relacionados
|
|
BRPI0606365A2
(pt)
*
|
2005-02-28 |
2017-06-27 |
Renovis Inc |
composto ou um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo e estereoisômeros e tautômeros do mesmo, composição farmacêutica, métodos para prevenir, tratar, melhorar ou controlar uma doença ou condição e para preparar um composto, uso de um composto ou um sal, solvato ou composição farmaceuticamente aceitável do mesmo, método de tratamento de um mamífero, e, combinação
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
CN101495116A
(zh)
|
2005-03-22 |
2009-07-29 |
哈佛大学校长及研究员协会 |
蛋白降解病症的治疗
|
|
KR20080031379A
(ko)
*
|
2005-07-11 |
2008-04-08 |
와이어쓰 |
글루타메이트 아그레카나제 저해제
|
|
JP4961773B2
(ja)
*
|
2005-07-29 |
2012-06-27 |
住友ベークライト株式会社 |
芳香族カルボン酸及びその酸ハロゲン化物
|
|
WO2007069020A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Vicuron Pharmaceuticals Inc. |
N-hydroxyamide derivatives possessing antibacterial activity
|
|
AU2007345292B2
(en)
*
|
2006-02-14 |
2013-10-31 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
CA2654540C
(en)
|
2006-05-03 |
2017-01-17 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
WO2007138304A1
(en)
|
2006-05-30 |
2007-12-06 |
Astrazeneca Ab |
1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors
|
|
DE102006033321A1
(de)
*
|
2006-07-17 |
2008-01-24 |
Westfälische Wilhelms-Universität Münster |
Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen
|
|
EP2049124A4
(en)
|
2006-07-20 |
2010-02-10 |
Merck & Co Inc |
PHOSPHOR DERIVATIVES AS HISTONDEACETYLASE HEMMER
|
|
AU2007276763B2
(en)
*
|
2006-07-24 |
2011-03-17 |
University Of Maryland, Baltimore |
Heme oxygenase inhibitors and methods of therapeutic use
|
|
TW200821276A
(en)
*
|
2006-08-18 |
2008-05-16 |
Leo Pharma As |
Substituted acetylenic compounds useful for the treatment of diseases
|
|
EP2057127B1
(en)
|
2006-08-31 |
2012-01-11 |
Schering Corporation |
Hydantoin derivatives useful as antibacterial agents
|
|
US7923004B2
(en)
*
|
2006-10-13 |
2011-04-12 |
Xtl Biopharmaceuticals Ltd. |
4-ethynyl pyrazole derivative compounds and methods for treatment of HCV
|
|
US8962825B2
(en)
|
2006-10-30 |
2015-02-24 |
Glaxosmithkline Intellectual Property Development Limited |
Hydroxamates as inhibitors of histone deacetylase
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
WO2008105515A1
(ja)
*
|
2007-02-28 |
2008-09-04 |
Taisho Pharmaceutical Co., Ltd. |
新規なヒドロキサム酸誘導体
|
|
JP2010520875A
(ja)
|
2007-03-09 |
2010-06-17 |
レノビス， インコーポレイテッド |
Ｐ２ｘ７調節因子としてのビシクロヘテロアリール化合物およびその使用
|
|
JP5539864B2
(ja)
*
|
2007-06-12 |
2014-07-02 |
アカオゲン，インコーポレーテッド |
抗菌剤
|
|
CN101417937B
(zh)
*
|
2007-10-23 |
2013-05-29 |
中山大学 |
β-醛酮类抗菌化合物及其应用
|
|
JP2011517313A
(ja)
|
2007-12-11 |
2011-06-02 |
ビアメト ファーマシューティカルズ，インク． |
金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
|
|
EP2234978B1
(en)
|
2007-12-20 |
2015-02-25 |
AstraZeneca AB |
Carbamoyl compounds as dgat1 inhibitors 190
|
|
ES2408932T3
(es)
|
2008-06-25 |
2013-06-24 |
Merck Sharp & Dohme Corp. |
Síntesis y uso de agentes antibacterianos heterocíclicos
|
|
RU2515611C2
(ru)
|
2008-07-23 |
2014-05-20 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Ингибиторы деацетилазы и их применение
|
|
CN102171185A
(zh)
*
|
2008-08-01 |
2011-08-31 |
拜奥西尼斯医药股份有限公司 |
甲硫氨酸类似物及其使用方法
|
|
EP2315746A1
(en)
*
|
2008-08-04 |
2011-05-04 |
Schering Corporation |
Urea derivatives as antibacterial agents
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
WO2010032147A2
(en)
*
|
2008-09-19 |
2010-03-25 |
Pfizer Inc. |
Hydroxamic acid derivatives useful as antibacterial agents
|
|
EP2361242B1
(en)
|
2008-10-17 |
2018-08-01 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
EP2177502A1
(en)
*
|
2008-10-17 |
2010-04-21 |
Oryzon Genomics, S.A. |
Compounds and their use
|
|
WO2010084160A1
(en)
|
2009-01-21 |
2010-07-29 |
Oryzon Genomics S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
WO2011005355A1
(en)
*
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
KR20120023663A
(ko)
*
|
2009-05-25 |
2012-03-13 |
키에시 파르마슈티시 엣스. 피. 에이. |
폐 계면활성제 및 스테로이드를 포함하는 치료적 조합
|
|
BRPI1016109A2
(pt)
|
2009-06-19 |
2016-05-17 |
Astrazeneca Ab |
"composto, composição farmacêutica, e, processo para preparar um composto"
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
RU2602814C2
(ru)
|
2009-09-25 |
2016-11-20 |
Оризон Дженомикс С.А. |
Лизинспецифические ингибиторы деметилазы-1 и их применение
|
|
US8946296B2
(en)
|
2009-10-09 |
2015-02-03 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
|
|
DK2512474T3
(en)
*
|
2009-12-16 |
2014-12-01 |
Pfizer |
N-linked hydroxamic acid derivatives which can be used as antibacterial agents
|
|
WO2011106573A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
WO2011106574A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibitors for antiviral use
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
RS55348B1
(sr)
|
2010-04-19 |
2017-03-31 |
Oryzon Gnomics S A |
Inhibitori lizin specifične demetilaze-1 i njihova upotreba
|
|
CA2796750C
(en)
*
|
2010-04-20 |
2017-09-19 |
Taisho Pharmaceutical Co., Ltd. |
Novel hydroxamic acid derivative
|
|
MX353408B
(es)
|
2010-04-22 |
2018-01-11 |
Vertex Pharma |
Proceso para producir compuestos de cicloalquilcarboxamido-indol.
|
|
WO2012013728A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
|
|
EP2598480B1
(en)
|
2010-07-29 |
2019-04-24 |
Oryzon Genomics, S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
WO2012031298A2
(en)
*
|
2010-09-03 |
2012-03-08 |
Duke University |
Ethynylbenzene derivatives
|
|
US9061966B2
(en)
|
2010-10-08 |
2015-06-23 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
EA201390626A1
(ru)
*
|
2010-11-10 |
2013-12-30 |
Эйкеоджен, Инк. |
Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
EP2661433B1
(en)
|
2011-01-04 |
2017-08-16 |
Novartis AG |
Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
|
|
WO2012107498A1
(en)
|
2011-02-08 |
2012-08-16 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
US8877940B2
(en)
|
2011-02-22 |
2014-11-04 |
Institut National De La Recherche Scientifique |
Antibiotic tolerance inhibitors
|
|
MA34963B1
(fr)
|
2011-03-07 |
2014-03-01 |
Pfizer |
Derives de fluoro-pyridinone utiles en tant qu'agents antibacteriens
|
|
WO2012137094A1
(en)
|
2011-04-08 |
2012-10-11 |
Pfizer Inc. |
Isoxazole derivatives useful as antibacterial agents
|
|
CA2830866A1
(en)
|
2011-04-08 |
2012-10-11 |
Pfizer Inc. |
Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
|
|
WO2013039947A1
(en)
|
2011-09-12 |
2013-03-21 |
Achaogen, Inc. |
Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide
|
|
JP6006609B2
(ja)
*
|
2011-10-19 |
2016-10-12 |
大正製薬株式会社 |
新規なヒドロキサム酸誘導体を含有する医薬
|
|
RU2668952C2
(ru)
|
2011-10-20 |
2018-10-05 |
Оризон Дженомикс, С.А. |
(гетеро)арилциклопропиламины в качестве ингибиторов lsd1
|
|
MX356344B
(es)
|
2011-10-20 |
2018-05-23 |
Oryzon Genomics Sa |
Compuestos de (hetero)arilciclopropilamina como inhibidores de lsd1.
|
|
US8999922B2
(en)
*
|
2012-02-16 |
2015-04-07 |
Rqx Pharmaceuticals, Inc. |
Linear peptide antibiotics
|
|
WO2013170165A1
(en)
|
2012-05-10 |
2013-11-14 |
Achaogen, Inc. |
Antibacterial agents
|
|
WO2014002054A1
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
ES2644700T3
(es)
|
2012-06-28 |
2017-11-30 |
Novartis Ag |
Derivados de pirrolidina y su uso como moduladores de la ruta del complemento
|
|
JP6273274B2
(ja)
|
2012-06-28 |
2018-01-31 |
ノバルティス アーゲー |
補体経路モジュレーターおよびその使用
|
|
CN104379579B
(zh)
|
2012-06-28 |
2017-03-08 |
诺华股份有限公司 |
吡咯烷衍生物及其作为补体途径调节剂的用途
|
|
JP6214647B2
(ja)
|
2012-06-28 |
2017-10-18 |
ノバルティス アーゲー |
補体経路モジュレーターおよびその使用
|
|
WO2014009833A2
(en)
|
2012-07-12 |
2014-01-16 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
CN103012207B
(zh)
*
|
2012-12-29 |
2015-05-27 |
吉首大学 |
二芳基丙酰-n-甲基氧肟酸类尿素酶抑制剂及其合成和用途
|
|
WO2014165075A1
(en)
*
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
JP6259814B2
(ja)
|
2013-03-15 |
2018-01-10 |
富山化学工業株式会社 |
新規なヒドロキサム酸誘導体またはその塩
|
|
WO2014160649A1
(en)
*
|
2013-03-29 |
2014-10-02 |
Novartis Ag |
Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
|
|
CA2921427A1
(en)
*
|
2013-08-16 |
2015-02-19 |
Duke University |
Substituted hydroxamic acid compounds
|
|
US10189786B2
(en)
|
2013-08-16 |
2019-01-29 |
Duke University |
Antibacterial compounds
|
|
US9908851B2
(en)
|
2013-08-16 |
2018-03-06 |
Duke University |
2-piperidinyl substituted N,3-dihydroxybutanamides
|
|
GB201315335D0
(en)
|
2013-08-29 |
2013-10-09 |
Of Singapore |
Amino diacids containing peptide modifiers
|
|
US9539305B1
(en)
*
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
RU2744460C2
(ru)
|
2014-04-15 |
2021-03-09 |
Вертекс Фармасьютикалз Инкорпорейтед |
Фармацевтические композиции для лечения заболеваний, опосредованных муковисцидозным трансмембранным регулятором проводимости
|
|
EP3134401B1
(en)
|
2014-04-22 |
2018-06-13 |
Novartis AG |
Isoxazoline hydroxamic acid derivatives as lpxc inhibitors
|
|
BR112017004796A2
(pt)
|
2014-09-12 |
2017-12-12 |
Toyama Chemical Co Ltd |
método para utilizar derivados de ácido hidroxâmico e substância antibacterial em combinação
|
|
RU2017112319A
(ru)
|
2014-09-12 |
2018-10-12 |
Тояма Кемикал Ко., Лтд. |
Новая фармацевтическая композиция, содержащая производное гидроксамовой кислоты или его соль
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
HRP20192009T1
(hr)
|
2014-12-16 |
2020-02-07 |
Novartis Ag |
Spojevi izoksazol hidroksamske kiseline kao inhibitori lpxc-a
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
KR20180011843A
(ko)
|
2015-06-11 |
2018-02-02 |
바실리어 파마슈티카 인터내셔널 리미티드 |
유출-펌프 억제제 및 이의 치료적 용도
|
|
WO2017042099A1
(en)
*
|
2015-09-09 |
2017-03-16 |
Basilea Pharmaceutica Ag |
Efflux-pump inhibitors and therapeutic uses thereof
|
|
EP3374355A4
(en)
|
2015-11-09 |
2019-04-17 |
Forge Therapeutics, Inc. |
COMPOUNDS BASED ON PYRONE AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS
|
|
WO2017083431A2
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
JP2019501896A
(ja)
*
|
2015-12-08 |
2019-01-24 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
抗菌化合物としての置換ベンザジノン
|
|
WO2017156071A1
(en)
|
2016-03-09 |
2017-09-14 |
Blade Therapeutics, Inc. |
Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
|
|
KR102410199B1
(ko)
*
|
2016-04-18 |
2022-06-17 |
프라운호퍼-게젤샤프트 츄어 푀르더룽 데어 안게반텐 포르슝에.파우. |
새로운 메프린 알파 및 베타 저해제
|
|
EP3448375B1
(en)
|
2016-04-25 |
2023-09-27 |
Duke University |
Benzoylglycine derivatives and methods of making and using same
|
|
SG11201810656WA
(en)
|
2016-06-14 |
2018-12-28 |
Novartis Ag |
Crystalline form of (r)-4-(5-(cyclopropylethynyl)isoxazol-3-yl)-n-hydroxy-2-methyl-2-(methylsulfonyl)butanamide as an antibacterial agent
|
|
HUE064412T2
(hu)
|
2016-06-21 |
2024-03-28 |
Orion Ophthalmology LLC |
Heterociklusos prolinamid-származékok
|
|
CA3026505A1
(en)
|
2016-06-21 |
2017-12-28 |
Orion Ophthalmology LLC |
Aliphatic prolinamide derivatives
|
|
JP7164521B2
(ja)
|
2016-06-21 |
2022-11-01 |
オリオン・オフサルモロジー・エルエルシー |
炭素環式プロリンアミド誘導体
|
|
TW201803847A
(zh)
|
2016-06-23 |
2018-02-01 |
美商爾察禎有限公司 |
抗菌劑
|
|
EP3481835A4
(en)
|
2016-07-05 |
2020-02-26 |
Blade Therapeutics, Inc. |
CALPAIN MODULATORS AND THERAPEUTIC USE THEREOF
|
|
BR112019006110A2
(pt)
|
2016-09-28 |
2019-09-10 |
Blade Therapeutics Inc |
moduladores de calpaína e usos terapêuticos dos mesmos
|
|
EP3558284A2
(en)
*
|
2016-12-23 |
2019-10-30 |
Intervet International B.V. |
Compounds for the treatment of bovine or swine respiratory disease
|
|
EP3558939A1
(en)
*
|
2016-12-23 |
2019-10-30 |
Intervet International B.V. |
Compounds useful for treating a mannheimia haemolytica or histophilus somni infection
|
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
|
WO2018213185A1
(en)
*
|
2017-05-17 |
2018-11-22 |
Drexel University |
Rela inhibitors for biofilm disruption
|
|
SG11202000230VA
(en)
|
2017-07-11 |
2020-02-27 |
Vertex Pharma |
Carboxamides as modulators of sodium channels
|
|
IL272188B
(en)
*
|
2017-07-27 |
2022-08-01 |
Biomendics Llc |
Claws replaced for bacterial colony regulation
|
|
WO2019154412A1
(zh)
|
2018-02-10 |
2019-08-15 |
山东亨利医药科技有限责任公司 |
作为抗菌素的化合物
|
|
IL281614B2
(en)
*
|
2018-09-20 |
2024-12-01 |
Blacksmith Medicines Inc |
Antibacterial compounds
|
|
CN112969700B
(zh)
|
2018-10-30 |
2024-08-20 |
吉利德科学公司 |
作为α4β7整合素抑制剂的咪唑并吡啶衍生物
|
|
KR102659859B1
(ko)
|
2018-10-30 |
2024-04-25 |
길리애드 사이언시즈, 인코포레이티드 |
알파4β7 인테그린의 억제를 위한 화합물
|
|
AU2019373242B2
(en)
|
2018-10-30 |
2023-07-13 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|
|
EP4541422A3
(en)
|
2018-10-30 |
2025-06-25 |
Gilead Sciences, Inc. |
Quinoline derivatives as alpha4beta7 integrin inhibitors
|
|
US12441703B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
CN113613638A
(zh)
*
|
2019-02-22 |
2021-11-05 |
希拉治疗公司 |
可吸入治疗剂
|
|
KR102908219B1
(ko)
|
2019-08-14 |
2026-01-08 |
길리애드 사이언시즈, 인코포레이티드 |
알파 4 베타 7 인테그린의 저해용 화합물
|
|
CN110563611B
(zh)
*
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
CA3164134A1
(en)
|
2019-12-06 |
2021-06-10 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
CN111254091B
(zh)
*
|
2020-01-20 |
2022-04-19 |
浙江工业大学 |
一种嗜麦芽窄食单胞菌gyh及其在降解氯代烃类污染物中的应用
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
PH12022553378A1
(en)
|
2020-06-10 |
2024-03-25 |
Univ Leuven Kath |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
SI4347031T1
(sl)
|
2021-06-04 |
2026-01-30 |
Vertex Pharmaceuticals Incorporated |
N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
|
|
JP2024525589A
(ja)
|
2021-07-09 |
2024-07-12 |
アリゴス セラピューティクス インコーポレイテッド |
抗ウイルス化合物
|
|
WO2023043816A1
(en)
|
2021-09-17 |
2023-03-23 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
JP2024536864A
(ja)
|
2021-09-28 |
2024-10-08 |
ブラックスミス メディシンズ，インク． |
Ｌｐｘｃ阻害剤およびその使用
|
|
WO2023128033A1
(ko)
*
|
2021-12-31 |
2023-07-06 |
(주)앰틱스바이오 |
감염성 진균의 바이오필름 생성을 억제하는 신규한 항진균용 조성물
|
|
CN116730870B
(zh)
*
|
2023-08-08 |
2023-10-13 |
中国医学科学院医药生物技术研究所 |
异羟肟酸类化合物或其可药用盐、及其用途和制备方法
|
|
CN119350185A
(zh)
*
|
2024-10-08 |
2025-01-24 |
聊城大学 |
一种联苯羟肟类衍生物及其制备方法和用途
|